Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Capital Expenditures (2021 - 2025)

Historic Capital Expenditures for Biofrontera (BFRI) over the last 5 years, with Q3 2025 value amounting to -$1000.0.

  • Biofrontera's Capital Expenditures changed N/A to -$1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$37000.0, marking a year-over-year decrease of 19024.39%. This contributed to the annual value of $10000.0 for FY2024, which is 10000.0% up from last year.
  • As of Q3 2025, Biofrontera's Capital Expenditures stood at -$1000.0.
  • Biofrontera's 5-year Capital Expenditures high stood at $57000.0 for Q1 2024, and its period low was -$40000.0 during Q4 2024.
  • Moreover, its 5-year median value for Capital Expenditures was $1000.0 (2022), whereas its average is $4571.4.
  • In the last 5 years, Biofrontera's Capital Expenditures tumbled by 100000.0% in 2023 and then soared by 30714.29% in 2024.
  • Over the past 5 years, Biofrontera's Capital Expenditures (Quarter) stood at $9000.0 in 2021, then tumbled by 88.89% to $1000.0 in 2022, then tumbled by 1000.0% to -$9000.0 in 2023, then crashed by 344.44% to -$40000.0 in 2024, then surged by 97.5% to -$1000.0 in 2025.
  • Its Capital Expenditures was -$1000.0 in Q3 2025, compared to $1000.0 in Q2 2025 and $3000.0 in Q1 2025.